Abstract

Abstract MicroRNAs (miRNA) are small noncoding RNAs commonly deregulated in cancer. The miR‐200 family (miR‐200a, ‐200b, ‐200c, ‐141 and ‐429) and miR‐205 are frequently silenced in advanced cancer and have been implicated in epithelial to mesenchymal transition (EMT) and tumor invasion by targeting the transcriptional repressors of E‐cadherin, ZEB1 and ZEB2 . ZEB1 is also known to repress miR‐200c‐141 transcription in a negative feedback loop, but otherwise little is known about the transcriptional regulation of the miR‐200 family and miR‐205. Recently, miR‐200 silencing was also reported in cancer stem cells, implying that miR‐200 deregulation is a key event in multiple levels of tumor biology. However, what prevents miR‐200 expression remains largely unanswered. Here we report concerted transcriptional regulation of the miR‐200 and miR‐205 loci in bladder tumors and bladder cell lines. Using a combination of miRNA expression arrays, qPCR assays and mass spectrometry DNA methylation analyses, we show that the miR‐200 and miR‐205 loci are specifically silenced and gain promoter hypermethylation and repressive chromatin marks in muscle invasive bladder tumors and undifferentiated bladder cell lines. Moreover, we report that miR‐200c expression is significantly correlated with early stage T1 bladder tumor progression, and propose miR‐200 and miR‐205 silencing and DNA hypermethylation as possible prognostic markers in bladder cancer. In addition, we observe that the mesoderm transcription factor TWIST1 and miR‐200 expression are inversely correlated in bladder tumor samples and cell lines. TWIST1 associates directly with the miR‐200 and miR‐205 promoters, and may act as a repressor of miR‐200 and miR‐205 expression.